Maine Revised Statutes Title 32 Sec. 13787-A – Sale of hypodermic apparatus
Current as of: 2023 | Check for updates
|
Other versions
1. Authorized seller. A hypodermic apparatus, as defined in Title 17?A, section 1101, subsection 2, may be sold only by a manufacturer or dealer of embalming supplies, manufacturer or dealer of medical or dental supplies, wholesale druggist, manufacturing pharmacist, pharmacist, veterinarian, agricultural supply store or manufacturer of surgical instruments.
[PL 1993, c. 394, §2 (NEW).]
Terms Used In Maine Revised Statutes Title 32 Sec. 13787-A
- dispensing: means the preparation and delivery of a prescription drug in a suitable container appropriately labeled for subsequent administration to or use by a patient or other individual entitled to receive the prescription drug pursuant to a lawful order of a practitioner. See Maine Revised Statutes Title 32 Sec. 13702-A
- Manufacturer: means a person engaged in the manufacture of prescription drugs. See Maine Revised Statutes Title 32 Sec. 13702-A
- Person: means an individual, corporation, partnership, association or any other legal entity. See Maine Revised Statutes Title 32 Sec. 13702-A
- Pharmacist: means an individual provider of health care services licensed by this State to engage in the practice of pharmacy. See Maine Revised Statutes Title 32 Sec. 13702-A
2. Purchaser. Any person who is 18 years of age or older may purchase a hypodermic apparatus from a seller described in subsection 1.
[PL 1993, c. 394, §2 (NEW).]
3. Criminal immunity.
[PL 2021, c. 434, §12 (RP).]
4. Immunity limited. This section does not limit prosecution for violation of any law prohibiting or regulating the use, possession, dispensing, distribution or promotion of controlled substances or scheduled drugs.
[PL 2021, c. 434, §13 (AMD).]
5. Medicaid not affected. This section does not diminish, expand or otherwise affect Medicaid reimbursement for hypodermic apparatuses.
[PL 1993, c. 394, §2 (NEW).]
SECTION HISTORY
PL 1993, c. 394, §2 (NEW). PL 2003, c. 688, §A39 (AMD). PL 2021, c. 434, §§12, 13 (AMD).